Digital health startup InfoBionic raised $8.2 million in a new round of equity financing, according to an SEC filing posted this week.
InfoBionic produces the MoMe Kardia wireless remote cardiac monitoring system designed to aid in the diagnosis of cardiac arrhythmias.
Money in the round came from 55 anonymous sources and the company is hoping to bring in another $308,055 before closing it, according to an SEC filing.
The company has yet to state how it intends to use funds raised in the round.
In March, InfoBionic said it won FDA 510(k) clearance for its next-gen MoMe Kardia wireless cardiac remote monitoring system.
The next-generation MoMe Kardia is a 3-in-1 single piece device that acquires and stores ECG and motion data and transmits them through the company’s cloud-based MoMe Software system for analysis, the Lowell, Mass.-based company said.
The company said data collected from the system is analyzed by proprietary algorithms, which identify data and flag it for physician review if necessary. The system requires no patient intervention to capture or analyze the data, but does inform the patient of the event trigger.
InfoBionic said it plans to begin shipping the next-gen MoMe Kardia in the 2nd quarter of 2016.